Sulfasalazine treatment for ankylosing spondylitis has a slow onset of action, generally after about 8 to 12 weeks of treatment may be effective, but due to individual differences may be shorter or longer onset of action.
Ankylosing spondylitis is an autoimmune disease, the current treatment is mainly to alleviate the symptoms and slow down the progress of the disease, the drug treatment can be followed by the application of non-steroidal anti-inflammatory drugs such as celecoxib, etc., to improve the condition of the anti-rheumatic drugs such as sulfasalazine, etc., glucocorticosteroids, such as prednisone acetate tablets, biologics, such as infliximab and so on.
Sulfasalazine is a sulfonamide antimicrobial drug, which can play the role of anti-inflammatory and limit the immune function, thus relieving the symptoms of ankylosing spondylitis pain. Sulfasalazine is slow to work and may usually take effect about 8 to 12 weeks after administration.
Common adverse reactions to salazosulfapyridine include digestive symptoms, rash, decreased blood counts, headache, dizziness, and decreased sperm in men. Sulfasalazine is contraindicated in people who are allergic to sulfonamides, pregnant women, nursing mothers, and children under 2 years of age.
Note that you should drink plenty of water and maintain a high flow of urine while taking the drug to prevent the emergence of crystalluria; allergy to furosemide, thiazide diuretics and other allergies may also occur with the use of this product.
Liuzosulfapyridine treatment of ankylosing spondylitis, the patient may not increase or decrease the dose of the drug without authorization, must strictly follow the doctor’s instructions to use the drug. It is recommended that patients with ankylosing spondylitis consult the rheumatology and immunology department in a timely manner and under the guidance of the doctor for standardized treatment.